Epileptic Syndromes
📧 Sign up to get email alerts when something new happens for Epileptic Syndromes.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-09EMA Authorised: Ztalmy (ganaxolone) — Marinus Pharmaceuticals Emerald Limited
Ztalmy (ganaxolone) has been authorised by the EMA for infantile spasms and related epileptic syndromes.
-
EMA approval · 2026-07-01EMA Authorised: Ztalmy (ganaxolone) — Marinus Pharmaceuticals Emerald Limited
Ztalmy (ganaxolone) has been authorised by the EMA for epileptic syndromes and infantile spasms, with orphan designation.
-
EMA approval · 2026-02-27EMA Authorised: Ztalmy (ganaxolone) — Marinus Pharmaceuticals Emerald Limited
The European Medicines Agency authorized Ztalmy (ganaxolone) for infantile epileptic spasms and related epileptic syndromes, marking EU appr…